NASDAQ:ARNA - Arena Pharmaceuticals News Headlines

$52.25
+0.31 (+0.60 %)
(As of 09/18/2019 03:37 PM ET)
Today's Range
$51.29
Now: $52.25
$52.73
50-Day Range
$50.70
MA: $55.07
$62.94
52-Week Range
$31.97
Now: $52.25
$64.48
Volume16,726 shs
Average Volume330,575 shs
Market Capitalization$2.60 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.55

Headlines

Arena Pharmaceuticals (NASDAQ ARNA) News Headlines

Source:
DateHeadline
Arena Pharmaceuticals to Present New Preclinical Atopic Dermatitis Data for Etrasimod at the European Society for Dermatologic Research Annual MeetingArena Pharmaceuticals to Present New Preclinical Atopic Dermatitis Data for Etrasimod at the European Society for Dermatologic Research Annual Meeting
finance.yahoo.com - September 17 at 9:25 AM
Ascendis Pharma Perhaps Not Best Of 76 Compared BiotechsAscendis Pharma Perhaps Not Best Of 76 Compared Biotechs
seekingalpha.com - September 12 at 10:25 AM
First Week of ARNA April 2020 Options TradingFirst Week of ARNA April 2020 Options Trading
www.nasdaq.com - September 12 at 10:25 AM
Insider Selling: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) EVP Sells 31,457 Shares of StockInsider Selling: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) EVP Sells 31,457 Shares of Stock
www.americanbankingnews.com - September 10 at 11:48 PM
Insider Selling: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) VP Sells 65,000 Shares of StockInsider Selling: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) VP Sells 65,000 Shares of Stock
www.americanbankingnews.com - September 10 at 11:48 PM
Arena Pharmaceuticals Presented New Patient-Reported Outcomes Data for Olorinab at the European Society of Neurogastroenterology & Motility NeuroGASTRO 2019 MeetingArena Pharmaceuticals Presented New Patient-Reported Outcomes Data for Olorinab at the European Society of Neurogastroenterology & Motility NeuroGASTRO 2019 Meeting
finance.yahoo.com - September 9 at 10:41 AM
Arena Pharmaceuticals (ARNA) Management Presents at Wells Fargo Global Healthcare Conference 2019 (Transcript)Arena Pharmaceuticals' (ARNA) Management Presents at Wells Fargo Global Healthcare Conference 2019 (Transcript)
seekingalpha.com - September 6 at 6:55 AM
Does Arena Pharmaceuticals, Inc.'s (NASDAQ:ARNA) CEO Salary Compare Well With Others?Does Arena Pharmaceuticals, Inc.'s (NASDAQ:ARNA) CEO Salary Compare Well With Others?
finance.yahoo.com - September 6 at 6:55 AM
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Given Consensus Rating of "Buy" by BrokeragesArena Pharmaceuticals, Inc. (NASDAQ:ARNA) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - August 31 at 6:47 AM
Zacks: Brokerages Anticipate Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Will Announce Quarterly Sales of $1.04 MillionZacks: Brokerages Anticipate Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Will Announce Quarterly Sales of $1.04 Million
www.americanbankingnews.com - August 28 at 1:02 AM
-$1.16 EPS Expected for Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) This Quarter-$1.16 EPS Expected for Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) This Quarter
www.americanbankingnews.com - August 26 at 10:16 PM
Arena Pharmaceuticals (ARNA) Q2 Loss Widens, Revenues MeetArena Pharmaceuticals' (ARNA) Q2 Loss Widens, Revenues Meet
www.nasdaq.com - August 8 at 10:06 PM
Noteworthy Thursday Option Activity: ARNA, TWLO, AVLRNoteworthy Thursday Option Activity: ARNA, TWLO, AVLR
www.nasdaq.com - August 8 at 5:04 PM
This Biotech Crashed On 'Erroneous' Report — Plus 2 Stocks That DivergedThis Biotech Crashed On 'Erroneous' Report — Plus 2 Stocks That Diverged
finance.yahoo.com - August 8 at 5:04 PM
Edited Transcript of ARNA earnings conference call or presentation 7-Aug-19 8:30pm GMTEdited Transcript of ARNA earnings conference call or presentation 7-Aug-19 8:30pm GMT
finance.yahoo.com - August 8 at 11:38 AM
Arena Pharmaceuticals Inc (ARNA) Q2 2019 Earnings Call TranscriptArena Pharmaceuticals Inc (ARNA) Q2 2019 Earnings Call Transcript
finance.yahoo.com - August 8 at 11:38 AM
Arena Pharmaceuticals' (ARNA) Q2 Loss Widens, Revenues MeetArena Pharmaceuticals' (ARNA) Q2 Loss Widens, Revenues Meet
finance.yahoo.com - August 8 at 11:38 AM
BRIEF-Arena Pharmaceuticals Q2 Loss Per Share $1.24BRIEF-Arena Pharmaceuticals Q2 Loss Per Share $1.24
www.msn.com - August 7 at 9:42 PM
Arena Pharmaceuticals EPS misses by $0.17, misses on revenueArena Pharmaceuticals EPS misses by $0.17, misses on revenue
seekingalpha.com - August 7 at 4:41 PM
Arena Reports Second Quarter Financial Results with Strong Liquidity Position, and Initiation of Etrasimod ELEVATE UC 52 and Olorinab CAPTIVATE TrialsArena Reports Second Quarter Financial Results with Strong Liquidity Position, and Initiation of Etrasimod ELEVATE UC 52 and Olorinab CAPTIVATE Trials
finance.yahoo.com - August 7 at 4:41 PM
Arena Pharmaceuticals Q2 2019 Earnings PreviewArena Pharmaceuticals Q2 2019 Earnings Preview
seekingalpha.com - August 6 at 9:54 PM
Is Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) A High Quality Stock To Own?Is Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) A High Quality Stock To Own?
finance.yahoo.com - August 6 at 4:53 PM
Strange: Bullish ARNA Analysts Actually See -3.78% DownsideStrange: Bullish ARNA Analysts Actually See -3.78% Downside
www.nasdaq.com - August 2 at 11:05 AM
First Week of ARNA September 20th Options TradingFirst Week of ARNA September 20th Options Trading
www.nasdaq.com - August 1 at 12:45 PM
United Therapeutics (UTHR) Q2 Earnings & Sales Beat, Down Y/YUnited Therapeutics (UTHR) Q2 Earnings & Sales Beat, Down Y/Y
finance.yahoo.com - August 1 at 12:45 PM
Arena Pharmaceuticals to Release Second Quarter 2019 Financial Results and Provide Corporate Update on August 7Arena Pharmaceuticals to Release Second Quarter 2019 Financial Results and Provide Corporate Update on August 7
finance.yahoo.com - July 31 at 11:50 AM
Dosing underway in mid-stage study of Arenas olorinab in IBS patients with abdominal painDosing underway in mid-stage study of Arena's olorinab in IBS patients with abdominal pain
seekingalpha.com - July 25 at 12:14 PM
Arena Pharmaceuticals Announces First Subject Dosed in CAPTIVATE Phase 2 Trial Evaluating Olorinab in Abdominal Pain Associated with Irritable Bowel SyndromeArena Pharmaceuticals Announces First Subject Dosed in CAPTIVATE Phase 2 Trial Evaluating Olorinab in Abdominal Pain Associated with Irritable Bowel Syndrome
finance.yahoo.com - July 25 at 12:14 PM
Arena Pharmaceuticals (ARNA) Upgraded to Buy: Here's WhyArena Pharmaceuticals (ARNA) Upgraded to Buy: Here's Why
finance.yahoo.com - July 25 at 12:14 PM
Should Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Be Your Next Stock Pick?Should Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Be Your Next Stock Pick?
finance.yahoo.com - July 9 at 4:34 PM
ARNA Crosses Above Average Analyst TargetARNA Crosses Above Average Analyst Target
www.nasdaq.com - July 3 at 10:24 AM
Biotech Acquisition Prospects As Handicapped By Market-MakersBiotech Acquisition Prospects As Handicapped By Market-Makers
seekingalpha.com - June 21 at 4:23 PM
Společnost Arena Pharmaceuticals oznámila podání dávky prvnímu subjektu v rámci globálního klinického hodnocení ELEVATE UC 52 fáze 3 vyhodnocujícího přípravek Etrasimod na ulcerózní kolitiduSpolečnost Arena Pharmaceuticals oznámila podání dávky prvnímu subjektu v rámci globálního klinického hodnocení ELEVATE UC 52 fáze 3 vyhodnocujícího přípravek Etrasimod na ulcerózní kolitidu
www.prnewswire.com - June 17 at 9:07 PM
Arena Pharmaceuticals Announces First Subject Dosed in ELEVATE UC 52 Global Phase 3 Trial Evaluating Etrasimod in Ulcerative ColitisArena Pharmaceuticals Announces First Subject Dosed in ELEVATE UC 52 Global Phase 3 Trial Evaluating Etrasimod in Ulcerative Colitis
finance.yahoo.com - June 17 at 12:07 PM
Arena Pharmaceuticals annonce le premier sujet à être recruté dans lessai mondial de phase 3 ELEVATE UC 52 évaluant létrasimod dans le traitement de la rectocolite hémorragiqueArena Pharmaceuticals annonce le premier sujet à être recruté dans l'essai mondial de phase 3 ELEVATE UC 52 évaluant l'étrasimod dans le traitement de la rectocolite hémorragique
www.prnewswire.com - June 17 at 11:22 AM
Arena Pharmaceuticals to Present at JMP Securities Life Sciences Conference on June 19Arena Pharmaceuticals to Present at JMP Securities Life Sciences Conference on June 19
finance.yahoo.com - June 13 at 11:04 AM
Why Is Arena Pharmaceuticals (ARNA) Up 9.1% Since Last Earnings Report?Why Is Arena Pharmaceuticals (ARNA) Up 9.1% Since Last Earnings Report?
finance.yahoo.com - June 7 at 7:19 PM
Does Market Volatility Impact Arena Pharmaceuticals, Inc.'s (NASDAQ:ARNA) Share Price?Does Market Volatility Impact Arena Pharmaceuticals, Inc.'s (NASDAQ:ARNA) Share Price?
finance.yahoo.com - June 6 at 4:34 PM
Jim Cramer Shares His Thoughts On Arena Pharmaceuticals, Yext And MoreJim Cramer Shares His Thoughts On Arena Pharmaceuticals, Yext And More
www.benzinga.com - May 20 at 10:31 AM
Cramers lightning round: Arena Pharmaceuticals, Yext, IAC, and moreCramer's lightning round: Arena Pharmaceuticals, Yext, IAC, and more
www.cnbc.com - May 17 at 7:33 PM
Arena Pharmaceuticals Presence at Digestive Disease Week (DDW) Reinforces Commitment to the Gastrointestinal Disease CommunityArena Pharmaceuticals' Presence at Digestive Disease Week (DDW) Reinforces Commitment to the Gastrointestinal Disease Community
finance.yahoo.com - May 17 at 11:09 AM
Arenas Etrasimod Possesses Positive Attributes, But It Is Not UniqueArena's Etrasimod Possesses Positive Attributes, But It Is Not Unique
seekingalpha.com - May 14 at 11:43 AM
All You Need to Know About Arena Pharmaceuticals (ARNA) Rating Upgrade to BuyAll You Need to Know About Arena Pharmaceuticals (ARNA) Rating Upgrade to Buy
finance.yahoo.com - May 13 at 11:25 AM
Arena Pharmaceuticals Inc (ARNA) Q1 2019 Earnings Call TranscriptArena Pharmaceuticals Inc (ARNA) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 11 at 11:27 AM
Did Business Growth Power Arena Pharmaceuticalss (NASDAQ:ARNA) Share Price Gain of 226%?Did Business Growth Power Arena Pharmaceuticals's (NASDAQ:ARNA) Share Price Gain of 226%?
finance.yahoo.com - May 10 at 11:33 AM
Did Business Growth Power Arena Pharmaceuticals's (NASDAQ:ARNA) Share Price Gain of 226%?Did Business Growth Power Arena Pharmaceuticals's (NASDAQ:ARNA) Share Price Gain of 226%?
finance.yahoo.com - May 10 at 11:33 AM
Edited Transcript of ARNA earnings conference call or presentation 8-May-19 8:30pm GMTEdited Transcript of ARNA earnings conference call or presentation 8-May-19 8:30pm GMT
finance.yahoo.com - May 10 at 11:33 AM
Stocks bounce off lows but remain pressured after Trump claims China ‘broke the deal’Stocks bounce off lows but remain pressured after Trump claims China ‘broke the deal’
finance.yahoo.com - May 9 at 4:19 PM
Arena Pharmaceutical shares slide after drug maker reports disappointing financial resultsArena Pharmaceutical shares slide after drug maker reports disappointing financial results
www.marketwatch.com - May 9 at 11:27 AM
Arena Pharmaceuticals misses by $2.17, revenue in-lineArena Pharmaceuticals misses by $2.17, revenue in-line
seekingalpha.com - May 9 at 11:27 AM
This page was last updated on 9/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel